A major global partnership aimed at fighting superbugs announced Thursday that it is investing up to $48 million in research projects, including potentially the first new classes of antibiotics in decades, to target the deadliest drug-resistant bacteria.
Democracy Dies in Darkness
Quest for new antibiotics gets first major funding from global partnership
By Lena H. Sun
March 30, 2017 at 11:00 a.m. EDT